STOCK TITAN

Ventas, Inc. SEC Filings

VTR NYSE

Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ventas's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ventas's regulatory disclosures and financial reporting.

Rhea-AI Summary

Ventas, Inc. (VTR): Director Michael J. Embler acquired 74.76 units payable in common stock on October 16, 2025 as dividend equivalents under the Non‑Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan. The transaction was coded “A” (acquisition) in Table I. The filing notes a reference price of $69.55 per share as of the grant date. After this credit, Embler beneficially owned 14,520.153 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ventas, Inc. (VTR) director Melody C. Barnes reported an acquisition of 74.76 shares of common stock on 10/16/2025. The shares reflect units credited as dividend equivalents under the Non-Employee Directors' Equity Award Deferral Program and are payable in common stock, consistent with her deferral election.

The filing cites a closing price of $69.55 per share on the grant date. After this transaction, Barnes directly owned 33,125.153 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Debra A. Cafaro, Chairman and CEO of Ventas, Inc. (VTR), reported transactions dated 10/01/2025 on Form 4 showing the exercise and sale of 10,322 shares. She exercised fully vested stock options with an exercise price of $65.45 that were exercisable from 05/04/2016 and scheduled to expire 05/04/2026. The shares were sold under a Rule 10b5-1 trading plan entered 03/28/2024 at a weighted average sale price of $70.237. After the transactions, her reported beneficial ownership was 1,145,695 shares and she holds 670,965 unexercised options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Peter J. Bulgarelli, an executive at Ventas, Inc. (VTR), reported two open-market sales executed under a Rule 10b5-1 trading plan entered on February 20, 2025. On 09/30/2025 he sold 2,040 shares at $69.99, reducing his stake to 119,042 shares. On 10/01/2025 he sold 2,554 shares at a weighted-average price of $70.2566, leaving him with 116,488 shares. The filing states the 10b5-1 plan covers these sales and discloses the reported price range of $69.9931 to $70.4706, with the reporting person offering to provide detailed per-trade quantities on request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

This Form 144 notice reports a proposed sale of 2,554 shares of Ventas, Inc. common stock through Northern Trust Securities with an aggregate market value of $179,435.36 and an approximate sale date of 10/01/2025. The filer acquired these shares as compensation shares on 01/25/2022 from Ventas, Inc.

The filing also discloses recent sales by the same person: 406 shares sold on 09/15/2025 for $28,418.94 and 2,040 shares sold on 09/30/2025 for $142,779.60. Outstanding shares reported on the form are 454,471,192, indicating the proposed sale is de minimis relative to total shares outstanding. The filer affirms no undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Ventas, Inc. (VTR) Form 144: This notice reports a proposed sale of 2,040 shares of Ventas common stock through Northern Trust Securities, Inc. on 09/30/2025 with an aggregate market value of $142,779.60. The shares were acquired as compensation shares on 01/25/2022 from Ventas, Inc. The filing also discloses that 406 shares were sold on 09/15/2025 by Peter J. Bulgarelli for $28,418.94. The filing includes the standard representation that the selling person does not possess undisclosed material adverse information and references Rule 10b5-1 plan adoption language, but no plan adoption date or signature block details are provided in the content supplied.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Peter J. Bulgarelli, an officer of Ventas, Inc. (VTR), reported a sale of common stock under a Rule 10b5-1 plan. The filing discloses that on 09/15/2025 Mr. Bulgarelli disposed of 406 shares at a weighted average price of $69.9974 per share. After the reported sale he beneficially owned 121,082 shares, held directly. The Form 4 notes the transaction was executed pursuant to a 10b5-1 trading plan entered into on February 20, 2025, and that the sale occurred in multiple transactions at prices ranging from $69.99 to $70.00. The form is signed by an attorney-in-fact on behalf of Mr. Bulgarelli on 09/17/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ventas, Inc. (VTR) Form 144 shows a proposed sale of 406 common shares through Northern Trust Securities with an aggregate market value of $28,418.94. The shares are scheduled for sale on or about 09/15/2025 on the NYSE.

The filer acquired these shares as compensation shares from Ventas, Inc. on 01/25/2022. The filing reports 454,471,192 shares outstanding for the issuer and notes no securities sold in the past three months by the account. The notice includes the standard representation that the selling person is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Debra A. Cafaro, Chairman and CEO of Ventas, Inc. (VTR), exercised 10,322 fully vested stock options on 09/02/2025 at an exercise price of $65.45 per share and simultaneously sold the 10,322 underlying shares under a Rule 10b5-1 trading plan entered 03/28/2024. The sales generated a weighted average sale price of $67.8031 per share. After these transactions the reporting person beneficially owns 1,145,695 shares and holds 681,287 unexercised options. The filing was signed on 09/04/2025 by an attorney-in-fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ventas, Inc. (VTR) Form 144 notice reports a proposed sale of common stock by an insider and recent related sales. The filer indicates a broker-assisted sale of 10,322 shares valued at $699,863.18 to occur on 09/02/2025 on the NYSE. The filing states the shares were acquired the same day by exercise of employee stock options from Ventas, Inc.

The filing also discloses five common-stock sales by the same person during July–August 2025 totaling 31,990 shares with aggregate gross proceeds listed per sale (largest single prior sale: 14,753 shares for $967,822.54). Total shares outstanding is shown as 454,471,192, which provides context for the size of the proposed sale relative to the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Ventas (VTR) SEC filings are available on StockTitan?

StockTitan tracks 157 SEC filings for Ventas (VTR), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Ventas (VTR)?

The most recent SEC filing for Ventas (VTR) was filed on October 16, 2025.